In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Back To School: Big Pharmas Test New Models For Tapping Academia

Executive Summary

Pfizer's ambitious tie-ups with multiple research institutions across several cities is but the latest model of academic-industry collaboration, highlighting pharma's ongoing hunger for fresh approaches to drug discovery.

Related Content

Eli Lilly's Open Source Approach To Early Stage Research
Sanofi Reworks R&D To Tackle Risk, Meet Unmet Need
Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q1 2011
Changing Pharma's Innovation DNA
Putting The Pieces Together Again: GSK Creates End-To-End Business Units
As Pfizer And UCSF Tighten Ties, More Deals With Academia Could Follow
Pharma: Serious About Change?
GSK Tries to Mimic Real-World Biotech
Lilly's Chorus Experiment
Novartis's Research Experiment


Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts